The last six months of life for patients with congestive heart failure

Journal of the American Geriatrics Society

Volumn 48, Issue S1, 2000, Pages S101-S109

  Levenson, James W ^a   McCarthy, Ellen P ^a   Lynn, Joanne ^b   Davis, Roger B ^a   Phillips, Russell S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

cardiopulmonary resuscitation; congestive heart failure; decision making; dyspnea; quality of life; terminal care

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CONGESTIVE HEART FAILURE; DEPRESSION; DISEASE SEVERITY; DYSPNEA; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; QUALITY OF LIFE; RESUSCITATION; SYMPTOMATOLOGY; TERMINAL CARE;

CLINICAL APPROACH/SOURCE; DEATH AND EUTHANASIA; EMPIRICAL APPROACH;

AGED; APACHE; ATTITUDE TO DEATH; CARDIOPULMONARY RESUSCITATION; DECISION MAKING; EMOTIONS; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TERMINAL CARE;

EID: 0034063573     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb03119.x     Document Type: Article

References (34)

1. Gillum RF,. Epidemiology of heart failure in the United States (editorial). Am Heart J 1993; 126: 1042-1047.
2. Rich MW,. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997; 45: 968-974.
3. Ho KK, Anderson KM, Kannel WB, et al,. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115.
4. Burns RB, McCarthy EP, Moskowitz MA, et al,. Outcomes for older men and women with congestive heart failure. J Am Geriatr Soc 1997; 45: 276-280.
5. Madsen BK, Rasmussen V, Hansen JF,. Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol 1997; 58: 151-162.
6. Chin MH, Goldman L,. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 1996; 156: 1814-1820.
7. Jaagosild P, Dawson NV, Thomas C, et al,. Outcomes of acute exacerbation of severe congestive heart failure: Quality of life, resource use, and survival. SUPPORT Investigators. The Study to Understand Prognosis and Preferences for Outcomes and Risks of Treatments. Arch Intern Med 1998; 158: 1081-1089.
8. Phillips RS, Wenger NS, Teno J, et al,. Choices of seriously ill patients about cardiopulmonary resuscitation: Correlates and outcomes. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med 1996; 100: 128-137.
9. Lynn J, Harrell FE, Cohn F, et al,. Defining the "terminally ill:" Insights from SUPPORT. Duq Law Rev 1996; 35: 311-336.
10. Lynn J, Harrell F, Cohn F, et al,. Prognoses of seriously ill hospitalized patients on the days before death: Implications for patient care and public policy. New Horiz 1997; 5: 56-61.
11. Murphy DJ, Cluff LE,. SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments: Study design. J Clin Epidemiol 1990; 43 (Suppl): 1-123S.
12. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 1995; 274: 1591-1598. (Published erratum appears in JAMA 1996;275:1232.).
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE,. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
14. Knaus WA, Wagner DP, Draper EA, et al,. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636.
15. Knaus WA, Harrell FE, Jr., Lynn J, et al,. The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1995; 122: 191-203.
16. Wu AW, Damiano AM, Lynn J, et al,. Predicting future functional status for seriously ill hospitalized adults. The SUPPORT prognostic model. Ann Intern Med 1995; 122: 342-350.
17. Katz S, Ford AB, Moskowitz RW, et al,. Studies of illness in the aged. The Index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-919.
18. Hlatky MA, Boineau RE, Higginbotham MB, et al,. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989; 64: 651-654.
19. Lynn J, Teno JM, Phillips RS, et al,. Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 1997; 126: 97-106.
20. Shacham S,. A shortened version of the Profile of Mood States. J Pers Assess 1983; 47: 305-306.
21. Krumholz HM, Phillips RS, Hamel MB, et al,. Resuscitation preferences among patients with severe congestive heart failure: Results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation 1998; 98: 648-655.
22. Chin MH, Goldman L,. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. Med Care 1998; 36: 1033-1046.
23. McCarthy EP, Phillips RS, Zhong Z, et al,. Dying with cancer: Patients' function, symptoms, and care preferences as death approaches. J Am Geriatr Soc 2000; 48 (suppl): S110-121.
24. Croft JB, Giles WH, Pollard RA, et al,. National trends in the initial hospitalization for heart failure. J Am Geriatr Soc 1997; 45: 270-275.
25. Lynn J,. An 88-year-old woman facing the end of life (clinical conference). JAMA 1997; 277: 1633-1640.
26. Jones S,. Palliative care in terminal cardiac failure (letter). BMJ 1995; 310: 1410-1411.
27. Gannon C,. Palliative care in terminal cardiac failure. Hospices cannot fulfil such a vast and diverse role (letter). BMJ 1995; 310: 1410-1411.
28. The Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. Lancet 1990; 336: 1-6. (Published erratum appears in Lancet 1990;336:698.).
29. Packer M, Carver JR, Rodeheffer RJ, et al,. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325: 1468-1475.
30. Cohn JN, Goldstein SO, Greenberg BH, et al,. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators. N Engl J Med 1998; 339: 1810-1816.
31. Cleland JG,. Are symptoms the most important target for therapy in chronic heart failure Prog Cardiovasc Dis 1998; 48: 59-64.
32. Stevenson LW,. Rites and responsibility for resuscitation in heart failure: Tread gently on the thin places (editorial). Circulation 1998; 98: 619-622.
33. Goldman S, Johnson G, Cohn JN, et al,. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87: VI24-31.
34. Covinsky KE, Goldman L, Cook EF, et al,. The impact of serious illness on patients' families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. JAMA 1994; 272: 1839-1844.